| BGF WORLD MINING E2 USD | RVI MATERIAS PRIMAS | 35,34% | 67,96% | 93,93% | 227,19% |
| GOLDMAN SACHS ASIA EQUITY PORTFOLIO A USD CAP | RVI ASIA EX-JAPÓN | 35,34% | 63,09% | 26,75% | 97,79% |
| GOLDMAN SACHS MULTI-MANAGER EMERGING MARKETS EQUITY PORTFOLIO P CAP USD | RVI EMERGENTES | 35,34% | 80,16% | 52,75% | 117,76% |
| HSBC GIF GLOBAL EMERGING MARKETS EQUITY AD USD | RVI EMERGENTES | 35,34% | 74,66% | 39,64% | 107,59% |
| ALGER SICAV - ALGER EMERGING MARKETS FUND I EU | RVI EMERGENTES | 35,33% | 66,14% | 22,63% | · |
| NINETY ONE GSF ASIA PACIFIC EQUITY OPPORTUNITIES FUND I ACC USD | RVI ASIA EX-JAPÓN | 35,33% | 93,08% | 62,77% | 173,78% |
| NORDEA 2 - BETAPLUS ENHANCED EMERGING MARKETS SUSTAINABLE EQUITY FUND BI2-EUR | RVI EMERGENTES | 35,33% | · | · | · |
| GOLDMAN SACHS NORTH AMERICA ENERGY & ENERGY INFRASTRUCTURE EQUITY PORTFOLIO P USD DIS | RVI ENERGÍA | 35,32% | 48,11% | 133,38% | 104,02% |
| GOLDMAN SACHS ASIA EQUITY PORTFOLIO A USD DIS | RVI ASIA EX-JAPÓN | 35,31% | 63,03% | 26,68% | 97,82% |
| CARMIGNAC PORTFOLIO EMERGENTS A EUR ACC | RVI EMERGENTES | 35,29% | 69,72% | 43,51% | 129,98% |
| LO FUNDS - ASIA HIGH CONVICTION (USD) N CAP | RVI ASIA EX-JAPÓN | 35,29% | 99,45% | 45,06% | · |
| POLAR CAPITAL BIOTECHNOLOGY S EUR DIS | RVI BIOTECNOLOGÍA | 35,29% | 92,66% | 83,61% | 338,49% |
| BNP PARIBAS FLEXI I COMMODITIES CLASSIC EUR DIS | RVI MATERIAS PRIMAS | 35,28% | 36,93% | 59,82% | · |
| NINETY ONE GSF ASIA PACIFIC EQUITY OPPORTUNITIES FUND IX ACC USD | RVI ASIA EX-JAPÓN | 35,28% | 92,85% | 62,39% | · |
| MAN UMBRELLA SICAV - MAN TREND ALTERNATIVE DN H EUR ACC | RENT. ABSOLUTA. VOLAT. ALTA | 35,26% | 10,62% | 19,50% | · |
| BGF JAPAN SMALL & MIDCAP OPPORTUNITIES A2 USD (HEDGED) | RVI JAPÓN SMALL/MID CAP | 35,25% | 100,03% | 127,88% | 297,17% |
| JANUS HENDERSON HF - JAPAN OPPORTUNITIES I2 JPY | RVI JAPÓN | 35,25% | 67,68% | 62,06% | · |
| NORDEA 2 - BETAPLUS ENHANCED EMERGING MARKETS SUSTAINABLE EQUITY FUND BI-EUR | RVI EMERGENTES | 35,25% | 88,84% | 66,08% | · |
| POLAR CAPITAL BIOTECHNOLOGY S USD DIS | RVI BIOTECNOLOGÍA | 35,25% | 92,86% | 83,54% | 335,63% |
| SCHRODER ISF QEP EMERGING MARKETS CORE I ACC EUR | RVI EMERGENTES VALOR | 35,25% | 89,44% | 60,07% | · |
